Environment & Health

One of the world’s leading environmental and health consultancies, we are trusted by clients to manage their most challenging environmental, health and social issues. We help clients understand and manage the impacts of their activities and products, so that they can respond to business, regulatory or legal challenges effectively and develop sound strategies for operating sustainably.

Ramboll Environment & Health: environmental and health sciences consulting services

Contact

Thomas R. Vetrano

President and Managing Director, Environment & Health

T: +1 973 286 4260

Joyce S. Schlesinger

PE, Executive VP, Global Practice Development

T: +1 703 516 2340

Mark A Travers

PG, Executive VP, Global Practice Development

T: +1 312-288-3890

Mette Søs Lassesen

Market Director

T: +1 202 304 3281

We have earned a reputation for technical and scientific excellence and innovation. Our independent science-first approach ensures that our strategic advice is objective and defensible.

Through our multidisciplinary global platform, we help clients around the world address some of the most important issues facing our global community, including the environmental and health implications of urbanisation, climate change and resource scarcity.

We continually strive to be at the forefront of our fields: delivering innovative, inspiring and sustainable solutions that set new standards and make a genuine difference to our customers, the environment and society as a whole.

More information

Environment & Health Market Brochure

Download our brochure

Events

Oct

2018

Oct

2018

Global CleanUp Congress

22-24 October 2018

Ramboll is sponsoring and participating in the inaugural Global CleanUp Congress in Coimbatore, India, 22-24 October 2018. Mark Travers presents Preparing for Climate Change in the Design of Cleanup Measures for Contaminant Impacted Land: A Global Perspective which is co-authored by Rambolle experts from the USA, Australia, India and Malaysia. Read the full story in our news section.

Oct

2018

Oct

2018

NAEM EHS & Sustainability Management Forum

23–26 October 2018

Meet our experts, including Monty Lovejoy and Alan Kao, at booth 208 at the NAEM EHS & Sustainability Management Forum in Louisville, KY, USA, and learn about our forward-thinking compliance, strategy and transaction services.

Oct

2018

Nov

2018

NUA Conference

1–2 November 2018

Craig Niles presents at the International Implementing the New Urban Agenda and SDGs Conference in Newcastle, NSW, Australia, 1–2 November. His presentation discusses economic growth for social and environmental prosperity, with case studies focusing on innovation districts in Moscow and Copenhagen.

Nov

2018

Fraunhofer IZM Environmental Conference

6 November 2018

Consultant Maximilian Kling presents at the Fraunhofer IZM Environmental Conference, addressing environmental policies and requirements including WEEE, RoHS and REACH to name but a few.

Nov

2018

Nov

2018

SETAC North America Annual Meeting

4-8 November 2018

Our experts participate in several platform and poster sessions at the 2018 Society of Environmental Toxicology and Chemistry (SETAC) North America Annual Meeting in Sacramento, California, USA, 4–8 November. View our full participation.We are a SETAC Global Partner and a proud sponsor of the annual meeting. Visit us at booth 612 in the exhibit hall to meet us and learn more about our innovative ecology-based strategies.

Nov

2018

Nov

2018

Waste Sweden Autumn Meeting

13–14 November 2018

Rebecka Jakobsson presents a new report on how to design recycling stations at Waste Sweden’s Autumn Meeting in Stockholm, 13–14 November.

Oct

2018

Nov

2018

EKOS Brasil

30 October–1 November 2018

Our experts lead a half-day workshop on ecological risk assessment (ERA) at the EKOS Brasil International Seminar for Remediation and Redevelopment of Contaminated Sites in Sao Paulo, Brazil, 30 October–1 November. We discuss the process for planning and conducting an ERA, including data collection, conceptual site modelling, selection of receptors and endpoints, characterization of risks and development of multiple lines of evidence supporting an ERA.